Fangcheng Li

MALAT1 is a prognostic factor in glioblastoma multiforme and induces chemoresistance to temozolomide through suppressing miR-203 and promoting thymidylate synthase expression

Wei Chen, Xinke Xu, Junliang Li et al. · Oncotarget · 2017 · 149 citations · Full text

Medicine, Molecular Medicine, Pharmacology +17

Suppression of tumorigenicity by MicroRNA-138 through inhibition of EZH2-CDK4/6-pRb-E2F1 signal loop in glioblastoma multiforme

Shuwei Qiu, Daquan Huang, Deling Yin et al. · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · 2013 · 111 citations

Life Sciences, Molecular Biology, Oncology +14

IGF-1 induces hypoxia-inducible factor 1α-mediated GLUT3 expression through PI3K/Akt/mTOR dependent pathways in PC12 cells

Jian Yu, Junliang Li, Shanyi Zhang et al. · Brain Research · 2011 · 69 citations

Life Sciences, Cell Biology, Molecular Biology +12

Rifampicin protects PC12 cells against MPP+-induced apoptosis and inhibits the expression of an α-Synuclein multimer

Jie Xu, Chuangzhen Wei, Changqing Xu et al. · Brain Research · 2007 · 54 citations

Life Sciences, Neuroscience, Pharmacology +12

Serpin peptidase inhibitor, clade A member 3 (SERPINA3), is overexpressed in glioma and associated with poor prognosis in glioma patients

Dingyuan Luo, Wei Chen, Tian Yun et al. · OncoTargets and Therapy · 2017 · 37 citations · Full text

Medicine, Molecular Biology, Oncology +17